Inventor · disambiguated record
Muthuraman Meiyappan
Also filed as: MEIYAPPAN MUTHURAMAN
12 granted patents·10 pending applications·28 citations·filing 2011–2023
87Inventor score
Files withSHIRE HUMAN GENETIC THERAPIES13TAKEDA PHARMACEUTICALS CO5SYNAGEVA BIOPHARMA CORP2CONCINO MICHAEL F1MEIYAPPAN MUTHURAMAN1
Top patents by PatentIndex Score
22 records- 0189US9814764B2Treatment of sanfilippo syndrome type b by intrathecal administration of alpha-n-acetylglucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2013·Granted Nov 14, 2017·9 cites·20 claims
- 0286US10722559B2Mannose-6-phosphate bearing peptides fused to lysosomal enzymesSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Jul 28, 2020·5 cites·11 claims
- 0383US11065307B2Therapeutic fusion protein comprising an alpha-n-acetylglucosaminidase and a lysosomal targeting moietySHIRE HUMAN GENETIC THERAPIES·Filed 2017·Granted Jul 20, 2021·2 cites·8 claims
- 0481US8945542B2Methods for treating lysosomal acid lipase deficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Granted Feb 3, 2015·8 cites·3 claims
- 0580US10603364B2Lysosomal targeting and uses thereofSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Mar 31, 2020·2 cites·7 claims
- 0675US2023365954A1Affinity purification of glycoside-cleaving enzymesTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 0769US8775146B2Crystal structure of human alpha-N-acetylglucosaminidaseMEIYAPPAN MUTHURAMAN·Filed 2011·Granted Jul 8, 2014·2 cites·5 claims
- 0867US11685912B2Affinity purification of glycosidase-cleaving enzymesTAKEDA PHARMACEUTICALS CO·Filed 2019·Granted Jun 27, 2023·0 cites·34 claims
- 0967US2023381287A1Formulations comprising glucocerebrosidase and isofagomineTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1063US2024034779A1Antibodies targeting complement factor d and uses therofTAKEDA PHARMACEUTICALS CO·Filed 2023·Application pending·0 cites
- 1161US9708590B2Crystal structure of human α-N-acetylglucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Jul 18, 2017·0 cites·20 claims
- 1256US2020376095A1Mannose-6-phosphate bearing peptides fused to lysosomal enzymesSHIRE HUMAN GENETIC THERAPIES·Filed 2020·Application pending·0 cites
- 1355US10729746B2Recombinant placenta growth factor for treating Duchenne muscular dystrophySHIRE HUMAN GENETIC THERAPIES·Filed 2014·Granted Aug 4, 2020·0 cites·15 claims
- 1452US12286400B2Isofagomine salts, methods of use and formulationsTAKEDA PHARMACEUTICALS CO·Filed 2020·Granted Apr 29, 2025·0 cites·18 claims
- 1552US2022133863A1Treatment of sanfilippo syndrome type bSHIRE HUMAN GENETIC THERAPIES·Filed 2021·Application pending·0 cites
- 1649US2020316178A1Formulations comprising glucocerebrosidase and isofagomineSHIRE HUMAN GENETIC THERAPIES·Filed 2018·Application pending·0 cites
- 1748US2013330317A1Methods for Treating Lysosomal Acid Lipase DeficiencySYNAGEVA BIOPHARMA CORP·Filed 2013·Application pending·0 cites
- 1842US9597376B2Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted Mar 21, 2017·0 cites·14 claims
- 1939US9957494B2Crystal structure of human four-phosphate adaptor protein 2 glycolipid transfer protein like domainSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Granted May 1, 2018·0 cites·14 claims
- 2039US2017202929A1Lipoprotein lipase for treatment of hypertriglyceridemic-related conditions including acute pancreatitisSHIRE HUMAN GENETIC THERAPIES·Filed 2017·Application pending·0 cites
- 2137US2017267986A1Generation of mannose-6-phosphate containing recombinant alpha-n-acetyl glucosaminidaseSHIRE HUMAN GENETIC THERAPIES·Filed 2015·Application pending·0 cites
- 2235US2011318327A1Treatment of sanfilippo syndrome type bCONCINO MICHAEL F·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →